Profile
Benoît Pastour currently works at Nord Capital Partenaires SAS, as Chief Executive Officer from 2010, Turenne Capital Partenaires SA, as Managing Director from 2016, Aterovax SA, as Director from 2013, and Altur Investissement SCA, as Executive Vice President.
Mr. Pastour also formerly worked at Vauban Partenaires SA, as Director-Participations from 1991 to 2007, DNA Therapeutics SASU, as Director, Biom'Up SA, as Director, and UniCredit SpA, as Head-LBO Financing.
Mr. Pastour received his graduate degree from Université Paris 1 Panthéon-Sorbonne and graduate degree from IÉSEG School of Management.
Benoît Pastour active positions
| Companies | Position | Start |
|---|---|---|
| ALTUR INVESTISSEMENT | Corporate Officer/Principal | 07/03/2011 |
Turenne Capital Partenaires SA
Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital invests in small and middle market companies located in France. The firm focuses on healthcare, hospitality, environment, energetic transition and innovacom sectors. It participates in seed, early and later stage transactions with an investment size of less than EUR 30 million. | Private Equity Investor | 29/02/2008 |
Nord Capital Partenaires SAS
Nord Capital Partenaires SAS Investment ManagersFinance Nord Capital Partenaires invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides financing for buyout and growth capital requirements with an investment size of EUR 1 -10 million. | Chief Executive Officer | 11/11/2010 |
Aterovax SA
Aterovax SA Medical/Nursing ServicesHealth Services Develops in vitro diagnostic products | Director/Board Member | 02/09/2013 |
Former positions of Benoît Pastour
| Companies | Position | End |
|---|---|---|
Vauban Partenaires SA
Vauban Partenaires SA Investment ManagersFinance VP is a regional private equity firm specialized in small and medium-sized companies with 3 to 200 million Euros in turnover. The firm invests across sectors in profitable businesses and targets situations including LBO, MBO, OBO and shareholder restructuration. They also participate in expansion financing. VP has a medium-term investment horizon, actively participates in strategic decisions and promotes acquisitions. Their regional focus covers Nord-Pas de Calais, Picardy, Normandy, the Loire Valley, Auvergne and Limousin. | Investment Committee Member | 30/11/2007 |
| BIOM'UP | Director/Board Member | - |
DNA Therapeutics SASU
DNA Therapeutics SASU BiotechnologyHealth Technology Engages in the development of drugs for cancer treatment | Director/Board Member | - |
| UNICREDIT S.P.A. | Corporate Officer/Principal | - |
Training of Benoît Pastour
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Turenne Capital Partenaires SA
Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital invests in small and middle market companies located in France. The firm focuses on healthcare, hospitality, environment, energetic transition and innovacom sectors. It participates in seed, early and later stage transactions with an investment size of less than EUR 30 million. | Finance |
Université Paris 1 Panthéon-Sorbonne
Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vauban Partenaires SA
Vauban Partenaires SA Investment ManagersFinance VP is a regional private equity firm specialized in small and medium-sized companies with 3 to 200 million Euros in turnover. The firm invests across sectors in profitable businesses and targets situations including LBO, MBO, OBO and shareholder restructuration. They also participate in expansion financing. VP has a medium-term investment horizon, actively participates in strategic decisions and promotes acquisitions. Their regional focus covers Nord-Pas de Calais, Picardy, Normandy, the Loire Valley, Auvergne and Limousin. | Finance |
Altur Investissement SCA
Altur Investissement SCA Investment ManagersFinance Acts as Private Equity Fund | Finance |
UniCredit SpA
UniCredit SpA Major BanksFinance Operates as a pan-European commercial bank | Finance |
DNA Therapeutics SASU
DNA Therapeutics SASU BiotechnologyHealth Technology Engages in the development of drugs for cancer treatment | Health Technology |
Biom'Up SA
Biom'Up SA Medical SpecialtiesHealth Technology Manufactures medical devices based on collagen technology | Health Technology |
Nord Capital Partenaires SAS
Nord Capital Partenaires SAS Investment ManagersFinance Nord Capital Partenaires invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides financing for buyout and growth capital requirements with an investment size of EUR 1 -10 million. | Finance |
Aterovax SA
Aterovax SA Medical/Nursing ServicesHealth Services Develops in vitro diagnostic products | Health Services |
IÉSEG School of Management
IÉSEG School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Benoît Pastour
















